$244 Million is the total value of JW Asset Management, LLC's 9 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESTA | ESTABLISHMENT LABS HLDGS INC | $117,342,000 | +103.1% | 3,117,485 | 0.0% | 48.03% | +43.9% | |
AMZN | AMAZON COM INC | $78,645,000 | +3.4% | 24,147 | 0.0% | 32.19% | -26.7% | |
GRWG | Sell | GROWGENERATION CORP | $37,251,000 | +138.4% | 926,176 | -5.3% | 15.25% | +68.9% |
HZNP | HORIZON THERAPEUTICS PUB L | $3,707,000 | -5.8% | 50,673 | 0.0% | 1.52% | -33.3% | |
PHAR | New | PHARMING GROUP NVspon ads | $2,949,000 | – | 1,895,941 | +100.0% | 1.21% | – |
BYND | Sell | BEYOND MEAT INC | $2,063,000 | -89.3% | 16,500 | -85.8% | 0.84% | -92.4% |
HYFM | New | HYDROFARM HLDGS GROUP INC | $1,315,000 | – | 25,000 | +100.0% | 0.54% | – |
HMCOU | New | HUMANCO ACQUISITION CORPunit 12/08/2023 | $937,000 | – | 85,000 | +100.0% | 0.38% | – |
ALIMERA SCIENCES INC | $116,000 | -13.4% | 27,552 | 0.0% | 0.05% | -39.0% | ||
ACB | Exit | AURORA CANNABIS INC | $0 | – | -51,879 | -100.0% | -0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
4 | 2024-01-02 |
SC 13D/A | 2024-01-02 |
4 | 2023-12-26 |
4 | 2023-12-19 |
4 | 2023-12-12 |
4 | 2023-12-07 |
4 | 2023-12-06 |
4 | 2023-11-21 |
4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.